Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses.

Sascha HeinMarie-Luise HerrleinInes MhedhbiDaniela BenderVanessa HabergerNuka BenzJonathan EisertJulia StinglMichael DreherDoris OberleJessica SchulzeChristin MacheMatthias BudtChristoph HildtThorsten WolffEberhard Hildt

Published in: Allergy (2021)

These data reveal differences in titer, neutralizing capacity, and affinity of the antibodies between BNT162b2- and CVnCoV-elicited sera, which could contribute to the apparent differences in vaccine efficacy.

Keyphrases

sars cov
electronic health record
genome wide
respiratory syndrome coronavirus
single cell
big data
computed tomography
zika virus
coronavirus disease
mass spectrometry
deep learning